A simple blood test would replace invasive pre-natal testing in future

A new technology that is currently under development at Sequenom, Inc. is expected to replace invasive pre-natal genetic screening procedures like amniocentesis and chorionic villus sampling, in future. This new non-invasive screening technique would be crucial to women with high-risk pregnancies, as it will have significant benefit to all expectant mothers, especially on the heels of new guidelines endorsed by the American College of Obstetricians and Gynecologists (ACOG) that call for risk assessment of all pregnancies for fetal chromosomal abnormalities.

Watch this video to know more about this new development.